Last 12 months
Inside the activity.
2 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 14, 2022 Filed Jul 15, 2022 16:18 UTC |
Vasista VittalChief Financial Officer
|
SaleCommon Stock | 468 | $30.00 | $14,040.00 |
DisclosureSEC source: 0001562180-22-005681 · primarydocument.xml · nonDerivative · entry 2 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,640 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 13, 2022 Filed Jul 15, 2022 16:18 UTC |
Vasista VittalChief Financial Officer
|
SaleCommon Stock | 4,332 | $30.01 | $129,988.16 |
DisclosureSEC source: 0001562180-22-005681 · primarydocument.xml · nonDerivative · entry 1 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,108 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.0000 to $30.0065. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 30, 2022 Filed Jan 4, 2024 16:22 UTC |
Danos OlivierChief Scientific Officer
|
GrantCommon Stock | 728 | $21.00 | $15,284.36 |
DisclosureSEC source: 0001562180-24-000249 · primarydocument.xml · nonDerivative · entry 1 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,678 F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the REGENXBIO Inc. Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of January 1, 2022 through June 30, 2022. This transaction is exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on June 30, 2022. Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 20:16 UTC |
Bennett JeanDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,324 | $0.00 Strike: $22.84 | $0.00 |
DisclosureSEC source: 0001562180-22-004873 · primarydocument.xml · derivative · entry 2 Bennett Jean · CIK 0001872219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,324 Underlying: Common Stock · 15,324 shares Expires 2032-06-03 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following June 3, 2022 while the optionee provides continuous service to the Issuer. Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 20:16 UTC |
Bennett JeanDirector
|
GrantCommon Stock | 3,010 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004873 · primarydocument.xml · nonDerivative · entry 1 Bennett Jean · CIK 0001872219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,010 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2023 while the recipient provides continuous service to the Issuer. Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 20:21 UTC |
MIGAUSKY GEORGE VDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,324 | $0.00 Strike: $22.84 | $0.00 |
DisclosureSEC source: 0001562180-22-004879 · primarydocument.xml · derivative · entry 2 MIGAUSKY GEORGE V · CIK 0001134365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,324 Underlying: Common Stock · 15,324 shares Expires 2032-06-03 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following June 3, 2022 while the optionee provides continuous service to the Issuer. Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 20:21 UTC |
MIGAUSKY GEORGE VDirector
|
GrantCommon Stock | 3,010 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004879 · primarydocument.xml · nonDerivative · entry 1 MIGAUSKY GEORGE V · CIK 0001134365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,010 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2023 while the recipient provides continuous service to the Issuer. Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 20:26 UTC |
Zachary JenniferDirector
|
GrantStock Option (Right to Buy) · Derivative | 29,739 | $0.00 Strike: $22.84 | $0.00 |
DisclosureSEC source: 0001562180-22-004883 · primarydocument.xml · derivative · entry 2 Zachary Jennifer · CIK 0001737231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,739 Underlying: Common Stock · 29,739 shares Expires 2032-06-03 F2 · derivative.exercise_date: The option will vest in equal monthly installments over the 36 months following June 3, 2022 while the optionee provides continuous service to the Issuer. Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 20:26 UTC |
Zachary JenniferDirector
|
GrantCommon Stock | 6,020 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004883 · primarydocument.xml · nonDerivative · entry 1 Zachary Jennifer · CIK 0001737231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,020 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). One-third of the shares subject to this RSU will vest on each of June 1, 2023, June 1, 2024 and June 1, 2025 while the recipient provides continuous service to the Issuer. Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 20:18 UTC |
Glucksmann AlexandraDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,324 | $0.00 Strike: $22.84 | $0.00 |
DisclosureSEC source: 0001562180-22-004876 · primarydocument.xml · derivative · entry 2 Glucksmann Alexandra · CIK 0001658390 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,324 Underlying: Common Stock · 15,324 shares Expires 2032-06-03 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following June 3, 2022 while the optionee provides continuous service to the Issuer. Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 20:18 UTC |
Glucksmann AlexandraDirector
|
GrantCommon Stock | 3,010 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004876 · primarydocument.xml · nonDerivative · entry 1 Glucksmann Alexandra · CIK 0001658390 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,010 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2023 while the recipient provides continuous service to the Issuer. Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 20:17 UTC |
Fox Allan M.Director
|
GrantStock Option (Right to Buy) · Derivative | 15,324 | $0.00 Strike: $22.84 | $0.00 |
DisclosureSEC source: 0001562180-22-004875 · primarydocument.xml · derivative · entry 2 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,324 Underlying: Common Stock · 15,324 shares Expires 2032-06-03 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following June 3, 2022 while the optionee provides continuous service to the Issuer. Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 20:17 UTC |
Fox Allan M.Director
|
GrantCommon Stock | 3,010 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004875 · primarydocument.xml · nonDerivative · entry 1 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,010 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2023 while the recipient provides continuous service to the Issuer. Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 20:22 UTC |
STUMP DAVID CDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,324 | $0.00 Strike: $22.84 | $0.00 |
DisclosureSEC source: 0001562180-22-004880 · primarydocument.xml · derivative · entry 2 STUMP DAVID C · CIK 0001191235 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,324 Underlying: Common Stock · 15,324 shares Expires 2032-06-03 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following June 3, 2022 while the optionee provides continuous service to the Issuer. Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 20:22 UTC |
STUMP DAVID CDirector
|
GrantCommon Stock | 3,010 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004880 · primarydocument.xml · nonDerivative · entry 1 STUMP DAVID C · CIK 0001191235 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,010 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2023 while the recipient provides continuous service to the Issuer. Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 20:20 UTC |
KARABELAS ARGERIS NDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,324 | $0.00 Strike: $22.84 | $0.00 |
DisclosureSEC source: 0001562180-22-004878 · primarydocument.xml · derivative · entry 2 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,324 Underlying: Common Stock · 15,324 shares Expires 2032-06-03 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following June 3, 2022 while the optionee provides continuous service to the Issuer. Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 20:20 UTC |
KARABELAS ARGERIS NDirector
|
GrantCommon Stock | 3,010 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004878 · primarydocument.xml · nonDerivative · entry 1 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,010 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2023 while the recipient provides continuous service to the Issuer. Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 20:23 UTC |
Tasse DanielDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,324 | $0.00 Strike: $22.84 | $0.00 |
DisclosureSEC source: 0001562180-22-004881 · primarydocument.xml · derivative · entry 2 Tasse Daniel · CIK 0001502785 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,324 Underlying: Common Stock · 15,324 shares Expires 2032-06-03 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following June 3, 2022 while the optionee provides continuous service to the Issuer. Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 20:23 UTC |
Tasse DanielDirector
|
GrantCommon Stock | 3,010 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004881 · primarydocument.xml · nonDerivative · entry 1 Tasse Daniel · CIK 0001502785 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,010 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2023 while the recipient provides continuous service to the Issuer. Read SEC document |
| January 20, 2022 Filed Jan 24, 2022 16:25 UTC |
Vasista VittalChief Financial Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 29,900 | $0.00 Strike: $0.85 | $0.00 |
DisclosureSEC source: 0001562180-22-000597 · primarydocument.xml · derivative · entry 2 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 29,900 shares Expires 2024-09-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 424,900 shares, became exercisable as follows: 284,683 of the shares subject to the option are initial shares ("Initial Shares") and 140,217 of the shares subject to the option are contingent shares ("Contingent Shares"). 72,235 of the Initial Shares vested on September 17, 2014, 53,112 of the Initial Shares vested on September 17, 2015 and an additional 4,426 of the Initial Shares vested upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter. F2 · derivative.exercise_date: (Continued from footnote 1) Notwithstanding the foregoing, 59,533 shares subject to this option that would otherwise have vested monthly between January 2018 and September 2018 were deemed vested as of December 31, 2015 on January 28, 2016 due to subsequent events. Read SEC document |
| January 20, 2022 Filed Jan 24, 2022 16:25 UTC |
Vasista VittalChief Financial Officer
|
Exercise / conversionCommon Stock | 29,900 | $0.85 | $25,415.00 |
DisclosureSEC source: 0001562180-22-000597 · primarydocument.xml · nonDerivative · entry 1 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,440 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 21:04 UTC |
Danos OlivierChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 51,100 | $0.00 Strike: $34.31 | $0.00 |
DisclosureSEC source: 0001562180-22-000156 · primarydocument.xml · derivative · entry 5 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,100 Underlying: Common Stock · 51,100 shares Expires 2032-01-03 F6 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 3, 2023 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 21:04 UTC |
Danos OlivierChief Scientific Officer
|
GrantCommon Stock | 10,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-000156 · primarydocument.xml · nonDerivative · entry 4 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,078 F5 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026 while the recipient provides continuous service to the Issuer. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 02:05 UTC |
PAKOLA STEVEChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 42,500 | $0.00 Strike: $34.31 | $0.00 |
DisclosureSEC source: 0001562180-22-000159 · primarydocument.xml · derivative · entry 4 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,500 Underlying: Common Stock · 42,500 shares Expires 2032-01-03 F4 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 3, 2023 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 02:05 UTC |
PAKOLA STEVEChief Medical Officer
|
GrantCommon Stock | 8,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-000159 · primarydocument.xml · nonDerivative · entry 3 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,150 F3 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026 while the recipient provides continuous service to the Issuer. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 02:05 UTC |
PAKOLA STEVEChief Medical Officer
|
SaleCommon Stock | 1,598 | $33.75 | $53,932.50 |
DisclosureSEC source: 0001562180-22-000159 · primarydocument.xml · nonDerivative · entry 2 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,250 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $33.72 to $33.81. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 02:01 UTC |
Mills Kenneth T.Director · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 170,188 | $0.00 Strike: $34.31 | $0.00 |
DisclosureSEC source: 0001562180-22-000149 · primarydocument.xml · derivative · entry 3 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,188 Underlying: Common Stock · 170,188 shares Expires 2032-01-03 F2 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 3, 2023 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 02:01 UTC |
Mills Kenneth T.Director · President and CEO
|
GrantCommon Stock | 35,796 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-000149 · primarydocument.xml · nonDerivative · entry 2 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,844 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026 while the recipient provides continuous service to the Issuer. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 21:07 UTC |
Vasista VittalChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 42,500 | $0.00 Strike: $34.31 | $0.00 |
DisclosureSEC source: 0001562180-22-000170 · primarydocument.xml · derivative · entry 2 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,500 Underlying: Common Stock · 42,500 shares Expires 2032-01-03 F2 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 3, 2023 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 21:07 UTC |
Vasista VittalChief Financial Officer
|
GrantCommon Stock | 8,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-000170 · primarydocument.xml · nonDerivative · entry 1 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,540 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026 while the recipient provides continuous service to the Issuer. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 02:06 UTC |
Simpson CurranChief Oper. & Tech. Officer
|
GrantStock Option (Right to Buy) · Derivative | 51,100 | $0.00 Strike: $34.31 | $0.00 |
DisclosureSEC source: 0001562180-22-000168 · primarydocument.xml · derivative · entry 3 Simpson Curran · CIK 0001346164 · Chief Oper. & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,100 Underlying: Common Stock · 51,100 shares Expires 2032-01-03 F2 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 3, 2023 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 02:06 UTC |
Simpson CurranChief Oper. & Tech. Officer
|
GrantCommon Stock | 10,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-000168 · primarydocument.xml · nonDerivative · entry 2 Simpson Curran · CIK 0001346164 · Chief Oper. & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,116 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026 while the recipient provides continuous service to the Issuer. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 02:03 UTC |
Christmas Patrick J.Chief Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 37,400 | $0.00 Strike: $34.31 | $0.00 |
DisclosureSEC source: 0001562180-22-000155 · primarydocument.xml · derivative · entry 3 Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,400 Underlying: Common Stock · 37,400 shares Expires 2032-01-03 F2 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 3, 2023 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 02:03 UTC |
Christmas Patrick J.Chief Legal Officer
|
GrantCommon Stock | 7,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-000155 · primarydocument.xml · nonDerivative · entry 2 Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,940 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026 while the recipient provides continuous service to the Issuer. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 21:04 UTC |
Danos OlivierChief Scientific Officer
|
Tax withholdingCommon Stock | 1,221 | $32.70 | $39,926.70 |
DisclosureSEC source: 0001562180-22-000156 · primarydocument.xml · nonDerivative · entry 3 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,378 Read SEC document |
| January 01, 2022 Filed Jan 5, 2022 02:05 UTC |
PAKOLA STEVEChief Medical Officer
|
Tax withholdingCommon Stock | 1,152 | $32.70 | $37,670.40 |
DisclosureSEC source: 0001562180-22-000159 · primarydocument.xml · nonDerivative · entry 1 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,848 Read SEC document |
| January 01, 2022 Filed Jan 5, 2022 02:01 UTC |
Mills Kenneth T.Director · President and CEO
|
Tax withholdingCommon Stock | 3,636 | $32.70 | $118,897.20 |
DisclosureSEC source: 0001562180-22-000149 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,048 Read SEC document |
| January 01, 2022 Filed Jan 5, 2022 02:06 UTC |
Simpson CurranChief Oper. & Tech. Officer
|
Tax withholdingCommon Stock | 1,332 | $32.70 | $43,556.40 |
DisclosureSEC source: 0001562180-22-000168 · primarydocument.xml · nonDerivative · entry 1 Simpson Curran · CIK 0001346164 · Chief Oper. & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,416 Read SEC document |
| January 01, 2022 Filed Jan 5, 2022 02:03 UTC |
Christmas Patrick J.Chief Legal Officer
|
Tax withholdingCommon Stock | 1,332 | $32.70 | $43,556.40 |
DisclosureSEC source: 0001562180-22-000155 · primarydocument.xml · nonDerivative · entry 1 Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,040 Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 21:04 UTC |
Danos OlivierChief Scientific Officer
|
GrantCommon Stock | 1 | $27.80 | $27.80 |
DisclosureSEC source: 0001562180-22-000156 · primarydocument.xml · nonDerivative · entry 2 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,599 F3 · security: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the ESPP for the ESPP purchase period of July 1, 2021 through December 31, 2021. This transaction is exempt under Rule 16b-3(c). F4 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on December 31, 2021. Read SEC document |
| December 23, 2021 Filed Dec 27, 2021 21:16 UTC |
Fox Allan M.Director
|
SaleCommon Stock | 6,323 | $35.85 | $226,663.74 |
DisclosureSEC source: 0001562180-21-007876 · primarydocument.xml · nonDerivative · entry 3 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Quaker Gray LLC Disclosed balance after: 1,529,981 F4 · price: This transaction was executed in multiple trades at prices ranging from $35.75 to $36.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: The reporting person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 23, 2021 Filed Dec 27, 2021 21:16 UTC |
Fox Allan M.Director
|
SaleCommon Stock | 44,908 | $34.92 | $1,568,120.00 |
DisclosureSEC source: 0001562180-21-007876 · primarydocument.xml · nonDerivative · entry 2 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Quaker Gray LLC Disclosed balance after: 1,536,304 F3 · price: This transaction was executed in multiple trades at prices ranging from $34.75 to $35.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: The reporting person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 22, 2021 Filed Dec 27, 2021 21:16 UTC |
Fox Allan M.Director
|
SaleCommon Stock | 61,638 | $34.40 | $2,120,575.26 |
DisclosureSEC source: 0001562180-21-007876 · primarydocument.xml · nonDerivative · entry 1 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Quaker Gray LLC Disclosed balance after: 1,581,212 F1 · price: This transaction was executed in multiple trades at prices ranging from $34.01 to $34.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: The reporting person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 02, 2021 Filed Dec 6, 2021 21:27 UTC |
Mills Kenneth T.Director · President and CEO
|
GiftCommon Stock | 3,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-007473 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,684 F1 · shares: This transaction involved an irrevocable gift of securities by the Reporting Person to a charitable donor advised fund. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 21:12 UTC |
Mills Kenneth T.Director · President and CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,500 | $0.00 Strike: $3.76 | $0.00 |
DisclosureSEC source: 0001562180-21-006967 · primarydocument.xml · derivative · entry 3 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,854 Underlying: Common Stock · 1,500 shares Expires 2025-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 275,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance vested in equal monthly installments over the 36 months thereafter. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 21:12 UTC |
Mills Kenneth T.Director · President and CEO
|
SaleCommon Stock | 1,500 | $40.00 | $60,000.00 |
DisclosureSEC source: 0001562180-21-006967 · primarydocument.xml · nonDerivative · entry 2 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,984 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 21:12 UTC |
Mills Kenneth T.Director · President and CEO
|
Exercise / conversionCommon Stock | 1,500 | $3.76 | $5,640.00 |
DisclosureSEC source: 0001562180-21-006967 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,484 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 27, 2021 Filed Sep 29, 2021 20:19 UTC |
Mills Kenneth T.Director · President and CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,500 | $0.00 Strike: $3.76 | $0.00 |
DisclosureSEC source: 0001562180-21-006147 · primarydocument.xml · derivative · entry 3 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,354 Underlying: Common Stock · 1,500 shares Expires 2025-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 275,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance vested in equal monthly installments over the 36 months thereafter. Read SEC document |
| September 27, 2021 Filed Sep 29, 2021 20:19 UTC |
Mills Kenneth T.Director · President and CEO
|
SaleCommon Stock | 1,500 | $42.19 | $63,285.00 |
DisclosureSEC source: 0001562180-21-006147 · primarydocument.xml · nonDerivative · entry 2 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,984 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 27, 2021 Filed Sep 29, 2021 20:19 UTC |
Mills Kenneth T.Director · President and CEO
|
Exercise / conversionCommon Stock | 1,500 | $3.76 | $5,640.00 |
DisclosureSEC source: 0001562180-21-006147 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,484 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.